Dosage errors may have tilted clinical heroin trial, B.C. court hears
Participants in a clinical trial fighting to receive prescription heroin may have failed conventional treatments only because they received inadequate dosages, a lawyer for the federal government has told a B.C. Supreme Court judge.
Lorne Lachance made his arguments on Wednesday, the second day of an injunction hearing that will determine whether select participants of the Vancouver-based heroin study will be able to receive a prescription version of the drug while a larger constitutional challenge is before the courts.
Andrea Woo Reports
Providence Health Care President and CEO Dianne Doyle